OBSIDIAN THERAPEUTICS
LIVE

Serial Number

99054596

Owner

Obsidian Therapeutics, Inc.

Attorney

Olivia Maria Baratta

Filing Date

Feb 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

OBSIDIAN THERAPEUTICS Trademark

Serial Number: 99054596

OBSIDIAN THERAPEUTICS is a trademark filed by Obsidian Therapeutics, Inc. on February 24, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Obsidian Therapeutics, Inc. (24 trademarks)

1030 Massachusetts Avenue, Fourth Floor
Cambridge, MA 02138

Entity Type: 03

Trademark Details

Filing Date

February 24, 2025

Registration Date

Not Registered

Published for Opposition

June 3, 2025

Goods & Services

Pharmaceutical preparations in the field of cell and gene therapies for the prevention and treatment of cardio-vascular system disorders, genitourinary system disorders, immune system disorders, metabolic system disorders, musculo-skeletal system disorders, nervous system disorders, respiratory system disorders, inflammatory disorders, and gastroenterological disorders.

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 8, 2026 EXRA
SOU EXTENSION 1 GRANTED
Apr 7, 2026 EX1G
SOU EXTENSION 1 FILED
Apr 7, 2026 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 7, 2026 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 7, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 3, 2025 NPUB
PUBLISHED FOR OPPOSITION
Jun 3, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 28, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 30, 2025 CNSA
EXAMINER'S AMENDMENT ENTERED
Apr 30, 2025 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Apr 30, 2025 GNEN
EXAMINERS AMENDMENT E-MAILED
Apr 30, 2025 GNEA
EXAMINERS AMENDMENT -WRITTEN
Apr 30, 2025 CNEA
ASSIGNED TO EXAMINER
Apr 21, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 24, 2025 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 24, 2025 NWOS
NEW APPLICATION ENTERED
Feb 24, 2025 NWAP